Disease modification in lupus nephritis: towards a pathophysiology-based treatment paradigm
Mieke van Schaik, Cees van Kooten, Laurent Arnaud, Annette Bruchfeld et autres
0 citationsNature Reviews Nephrology
Ana Malvar
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
111Publications signalées
3925Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Systemic Lupus Erythematosus ResearchRenal Diseases and GlomerulopathiesRenal Transplantation Outcomes and TreatmentsLiver Diseases and ImmunityChronic Kidney Disease and Diabetes
Publications récentes
Insights from the BLISS-LN Phase 3 study of biomarker associations with kidney response to belimumab in lupus nephritis
Brad H. Rovin, Richard Furie, Ana Malvar, Cynthia Aranow et autres
1 citationKidney International
P019 Obinutuzumab demonstrates steroid-sparing effects and consistent benefit in patients with lupus nephritis when using multiple primary endpoint definitions: secondary analysis of the REGENCY trial results
Brad H Rovin, Jay P Garg, Richard Furie, Rachel Jones et autres
0 citationsLara D. Veeken
P021 Obinutuzumab induces histological remission and deep kidney parenchymal B-cell depletion in patients with lupus nephritis: exploratory analyses from the REGENCY trial
Brad H Rovin, Elsa Martins, Cary D. Austin, Harini Raghu et autres
1 citationLara D. Veeken
E006 Kidney-related outcomes with obinutuzumab in patients with active lupus nephritis: a pre-specified exploratory analysis ofthe REGENCY trial
Brad H Rovin, William F. Pendergraft, L Lightstone, Eric Daugas et autres
0 citationsLara D. Veeken
Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Jürgen Floege, Isabelle Ayoub, Silke R. Brix, Kirk N. Campbell et autres
3 citationsKidney International
WCN26-3469 OBINUTUZUMAB INDUCES HISTOLOGIC REMISSION AND DEEP KIDNEY PARENCHYMAL B-CELL DEPLETION IN PATIENTS WITH LUPUS NEPHRITIS: EXPLORATORY ANALYSES FROM THE REGENCY TRIAL
B.H. Rovin, Elsa Martins, Cary D. Austin, Harini Raghu et autres
0 citationsKidney International Reports
Systematic Review of Trial Design and End Points in Lupus Nephritis
Sophia Giang, Maria A. Dall'Era, Rachel B. Jones, Liz Lightstone et autres
0 citationsKidney International Reports
Building CRESCENDO – a global registry of glomerulonephritis with crescents
Vanja Ivković, Andreas Kronbichler, Annette Bruchfeld, CRESCENDO Inves gators et autres
0 citationsClinical Kidney Journal
PO:11:279 Serious infection events associated with obinutuzumab in lupus nephritis: a secondary analysis of the phase III regency trial
Rovin Bh, Frederic Boissard, Bongin Yoo, William F Pendergraft et autres
0 citations
PO:07:188 Cluster analysis of socioeconomic and environmental determinants modifying activity, chronicity and clinical manifestations of systemic lupus erythematosus in the GLADEL 2.0 cohort
Romina Nieto, M C Téllez Martinez, Karen Roberts, Rosana Quintana et autres
0 citations
PT2:06 Obinutuzumab induces histological remission and deep kidney parenchymal B-cell depletion in patients with lupus nephritis: exploratory analyses of the phase III regency trial
Brad H Rovin, Elsa Martins, C B Austin, Harini Raghu et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.